InnoCare Pharma Ltd
SSE:688428

Watchlist Manager
InnoCare Pharma Ltd Logo
InnoCare Pharma Ltd
SSE:688428
Watchlist
Price: 28.31 CNY 9.31% Market Closed
Market Cap: 23.9B CNY
Have any thoughts about
InnoCare Pharma Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
InnoCare Pharma Ltd

Wall Street analysts forecast InnoCare Pharma Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for InnoCare Pharma Ltd is 23.27 CNY with a low forecast of 19.8 CNY and a high forecast of 27.03 CNY.

Lowest
Price Target
19.8 CNY
30% Downside
Average
Price Target
23.27 CNY
18% Downside
Highest
Price Target
27.03 CNY
5% Downside
InnoCare Pharma Ltd Competitors:
Price Targets
CRNX
Crinetics Pharmaceuticals Inc
136% Upside
300142
Walvax Biotechnology Co Ltd
21% Downside
302440
SK Bioscience Co Ltd
17% Downside
AMRN
Amarin Corporation PLC
20% Downside
214450
PharmaResearch Co Ltd
23% Downside
4593
Healios KK
9% Downside
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
12% Downside
IKT
Inhibikase Therapeutics Inc
308% Upside

Revenue
Forecast

Revenue Estimate
InnoCare Pharma Ltd

For the last 3 years the compound annual growth rate for InnoCare Pharma Ltd's revenue is -1%. The projected CAGR for the next 3 years is 33%.

-1%
Past Growth
33%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
InnoCare Pharma Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss

Net Income
Forecast

Net Income Estimate
InnoCare Pharma Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is InnoCare Pharma Ltd's stock price target?
Price Target
23.27 CNY

According to Wall Street analysts, the average 1-year price target for InnoCare Pharma Ltd is 23.27 CNY with a low forecast of 19.8 CNY and a high forecast of 27.03 CNY.

What is InnoCare Pharma Ltd's Revenue forecast?
Projected CAGR
33%

For the last 3 years the compound annual growth rate for InnoCare Pharma Ltd's revenue is -1%. The projected CAGR for the next 3 years is 33%.

Back to Top